Steward Partners Investment Advisory’s Twist Bioscience TWST Stock Holding History

Steward Partners Investment Advisory’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5K	Sell	102 -4	-4%	-$260	﹤0.01%	3714
2026 Q1	$5.04K	Hold	106	–	–	﹤0.01%	3794
2025 Q4	$3.36K	Hold	106	–	–	﹤0.01%	3820
2025 Q3	$2.98K	Buy	106 +102	+2,550%	+$3.09K	﹤0.01%	3808
2025 Q2	$147	Hold	4	–	–	﹤0.01%	4031
2025 Q1	$157	Buy	+4	New	+$180	﹤0.01%	3933
2024 Q2	–	Sell	-1,050	Closed	-$36K	–	3721
2024 Q1	$36K	Hold	1,050	–	–	﹤0.01%	2264
2023 Q4	$38.7K	Hold	1,050	–	–	﹤0.01%	2102
2023 Q3	$21.3K	Hold	1,050	–	–	﹤0.01%	2275
2023 Q2	$21.5K	Hold	1,050	–	–	﹤0.01%	2255
2023 Q1	$15.8K	Hold	1,050	–	–	﹤0.01%	2352
2022 Q4	$25K	Hold	1,050	–	–	﹤0.01%	2132
2022 Q3	$37K	Hold	1,050	–	–	﹤0.01%	1934
2022 Q2	$37K	Hold	1,050	–	–	﹤0.01%	1953
2022 Q1	$52K	Hold	1,050	–	–	﹤0.01%	1896
2021 Q4	$81K	Hold	1,050	–	–	﹤0.01%	1685
2021 Q3	$112K	Hold	1,050	–	–	﹤0.01%	1502
2021 Q2	$140K	Buy	+1,050	New	+$122K	﹤0.01%	1837

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Steward Partners Investment Advisory's TWST Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Twist Bioscience (TWST) stake by 3.8% in Q2 2026, selling an estimated $260 and leaving 102 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3714.

Steward Partners Investment Advisory first reported a position in TWST in Q2 2021 and has held it in 18 quarters since. The position peaked at $140K in Q2 2021. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Steward Partners Investment Advisory held 102 shares of Twist Bioscience worth $10.5K as of Q2 2026.
Steward Partners Investment Advisory sold 4 Twist Bioscience shares in Q2 2026, an estimated $260.
Twist Bioscience made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3714 holding.
Steward Partners Investment Advisory first reported a position in Twist Bioscience in Q2 2021 and has held it in 18 quarters since.
Steward Partners Investment Advisory's Twist Bioscience position peaked at $140K in Q2 2021.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.